Home    Back

 Drug    DrugBank | All Description Patterns

   e.g. "Sirolimus", "Adalimumab"

A    B    C    D    E    F    G    H     I     J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    other

91 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   Drug (Description in trials)   DrugBank   KEGG DRUG *   KEGG GENES * 
 [Number of genes] 		  KEGG PATHWAY 
 [Number of pathways] 		  Disease ID * 
 [Number of diseases] 
 1   0.9% sodium chloride   Sodium chloride   D02056   -   -   [3]
6,
14,
51 
 2   10% intravenous immunoglobulin (ivig)   Immune globulin human   -   -   -   [1]
14 
 3   Albumin (human) 25%, united states pharmacopeia (usp)   -   -   -   -   [2]
13,
14 
 4   Anti-c5 antibody   -   -   -   -   [4]
11,
14,
62,
109 
 5   Anti-thymocyte globulin   -   -   -   -   [18]
11,
13,
14,
36,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
164,
283,
284,
285 
 6   Carmustine   Carmustine   D00254   -   -   [5]
11,
13,
14,
28,
60 
 7   Chloride   Chloride ion   -   -   -   [17]
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299 
 8   Clairyg 50 mg/ml   -   -   -   -   [1]
14 
 9   Clairyg 50mg/ml   -   -   -   -   [1]
14 
 10   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   [43]
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 11   Cyclosporin   Ciclosporin   D00184   [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   [30] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   [16]
14,
38,
39,
49,
53,
56,
60,
62,
63,
97,
113,
164,
222,
223,
274,
326 
 12   Cyclosporin a   Ciclosporin   D00184   [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   [30] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   [11]
14,
38,
39,
49,
53,
56,
60,
62,
63,
113,
164 
 13   Cyclosporine   Ciclosporin   D00184   [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   [30] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   [33]
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 14   Cytarabine   Cytarabine   D00168, D03046, D03637   -   -   [6]
11,
13,
14,
25,
49,
60 
 15   Eculizumab   Eculizumab   D03940   [1] C5   [7] Complement and coagulation cascades, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Pertussis, Prion diseases, Staphylococcus aureus infection, Systemic lupus erythematosus   [7]
11,
13,
14,
62,
109,
222,
223 
 16   Etoposide   Etoposide   D00125, D04107   [2] TOP2A, TOP2B   [1] Platinum drug resistance   [11]
11,
13,
14,
26,
28,
34,
60,
65,
85,
164,
331 
 17   Fibrinogen   Fibrinogen human   -   -   -   [3]
14,
65,
288 
 18   Fibrinogen concentrate   Fibrinogen human   -   -   -   [1]
14 
 19   Fingolimod   Fingolimod   D10001   [1] S1PR1   [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   [3]
13,
14,
156 
 20   Freeze-dried sulfonated human normal immunoglobulin (ggs)   Immune globulin human   -   -   -   [3]
14,
43,
45 
 21   Fty720   -   -   -   -   [2]
13,
14 
 22   Gammanorm   -   -   -   -   [2]
14,
65 
 23   H.p. acthar® gel   -   -   -   -   [1]
14 
 24   Hematopoietic stem cell transplantation   -   -   -   -   [12]
11,
13,
14,
19,
20,
35,
46,
49,
51,
96,
234,
285 
 25   Hizentra   Immune globulin human   -   -   -   [2]
14,
65 
 26   Hizentra®   Immune globulin human   -   -   -   [2]
14,
65 
 27   Human immunoglobulin g   Immune globulin human   -   -   -   [3]
14,
50,
63 
 28   Human normal 10% immunoglobulin for intravenous administration   -   -   -   -   [1]
14 
 29   Human normal immunoglobulin   Immune globulin human   -   -   -   [8]
11,
13,
14,
43,
45,
50,
63,
65 
 30   Human normal immunoglobulin (iv)   Immune globulin human   -   -   -   [4]
11,
14,
63,
65 
 31   Human normal immunoglobulin (scig)   Immune globulin human   -   -   -   [1]
14 
 32   Human normal immunoglobulin for intravenous administration   Immune globulin human   -   -   -   [2]
14,
65 
 33   Human normal immunoglobulin g (igg > 98% purity)   Immune globulin human   -   -   -   [2]
14,
63 
 34   Hyqvia   Immune globulin human   -   -   -   [2]
14,
65 
 35   Hyqvia 100 mg/ml solution for infusion for subcutaneous use   Immune globulin human   -   -   -   [2]
14,
65 
 36   I10e   -   -   -   -   [3]
14,
63,
65 
 37   I10e (human normal immunoglobulin for intravenous administration 100mg/ml)   Immune globulin human   -   -   -   [1]
14 
 38   Igiv   -   -   -   -   [1]
14 
 39   Igiv, 10%   -   -   -   -   [2]
14,
65 
 40   Igpro10   -   -   -   -   [3]
14,
51,
65 
 41   Igpro20   -   -   -   -   [3]
14,
51,
65 
 42   Igpro20 (high dose)   -   -   -   -   [1]
14 
 43   Igpro20 (low dose)   -   -   -   -   [1]
14 
 44   Igvena*fl 200ml 10g+set   -   -   -   -   [1]
14 
 45   Immune globulin   -   -   -   -   [3]
11,
13,
14 
 46   Immune globulin 10% intravenous solution   -   -   -   -   [1]
14 
 47   Immune globulin intravenous   Immune globulin human   -   -   -   [3]
14,
63,
65 
 48   Immune globulin intravenous (human), 10%   Immune globulin human   -   -   -   [2]
14,
65 
 49   Immune globulin iv (human), 10% caprylate/chromatography purified   -   -   -   -   [1]
14 
 50   Immune globulin subcutaneous   Immune globulin human   -   -   -   [2]
14,
65 
 51   Immune globulin subcutaneous (human)   Immune globulin human   -   -   -   [2]
14,
65 
 52   Immunoglobulin   -   -   -   -   [2]
13,
14 
 53   Immunoglobulin g   Immune globulin human   -   -   -   [7]
11,
13,
14,
49,
50,
63,
65 
 54   Immunoglobulin perfusion   -   -   -   -   [1]
14 
 55   Immunoglobuline g   -   -   -   -   [1]
14 
 56   Immunoglobulins   -   -   -   -   [1]
14 
 57   Immunoglobulins, normal human, for intravascular adm.   -   -   -   -   [2]
14,
15 
 58   Interferon beta   Human interferon beta   -   -   -   [6]
13,
14,
20,
26,
96,
97 
 59   Interferon beta-1a   Human interferon beta   -   -   -   [5]
13,
14,
26,
96,
97 
 60   Intravenous gammaglobulin   -   -   -   -   [1]
14 
 61   Intravenous immunoglobulin   Immune globulin human   -   -   -   [16]
2,
11,
14,
17,
18,
35,
38,
39,
49,
51,
63,
65,
85,
164,
296,
309 
 62   Intravenous immunoglobulin (ivig)   Immune globulin human   -   -   -   [4]
14,
17,
164,
296 
 63   Iqymune   -   -   -   -   [1]
14 
 64   Ivig   Immune globulin human   -   -   -   [12]
11,
13,
14,
17,
18,
50,
51,
63,
65,
85,
164,
296 
 65   Kiovig   Immune globulin human   -   -   -   [2]
14,
65 
 66   Kiovig 100 mg/ml solution for infusion   Immune globulin human   -   -   -   [2]
14,
65 
 67   Kiovig® (human normal immunoglobulin for intravenous administration 100mg/ml)   Immune globulin human   -   -   -   [1]
14 
 68   Lipoic acid   Lipoic acid   D00048, D00086   -   -   [5]
2,
5,
13,
14,
20 
 69   Md1003   -   -   -   -   [5]
2,
10,
13,
14,
20 
 70   Melphalan   Melphalan   D00369   -   -   [14]
11,
13,
14,
19,
20,
28,
60,
62,
65,
96,
164,
234,
284,
285 
 71   Mycophenolate   Mycophenolic acid   D05096   [2] IMPDH1, IMPDH2   [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   [33]
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 72   Mycophenolate mofetil   Mycophenolate mofetil   D00752, D05094, D05095   [2] IMPDH1, IMPDH2   [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   [32]
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 73   Newgam   -   -   -   -   [3]
14,
63,
65 
 74   Newgam 10%   -   -   -   -   [1]
14 
 75   Npb-01   -   -   -   -   [3]
13,
14,
162 
 76   Null   -   -   -   -   [17]
6,
13,
14,
15,
28,
37,
46,
49,
51,
63,
86,
90,
96,
97,
107,
145,
271 
 77   Panzyga   Immune globulin human   -   -   -   [1]
14 
 78   Placebo   -   -   -   -   [20]
3,
6,
13,
14,
40,
46,
49,
50,
51,
66,
67,
79,
85,
86,
88,
96,
97,
144,
149,
226 
 79   Prednisone   Prednisone   D00473   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [43]
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 80   Privigen   Immune globulin human   -   -   -   [4]
11,
14,
51,
65 
 81   Privigen®   Immune globulin human   -   -   -   [2]
14,
63 
 82   Rhuph20   -   -   -   -   [2]
13,
14 
 83   Rituximab   Rituximab   D02994   [1] MS4A1   [1] Hematopoietic cell lineage   [42]
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 84   Rozanolixizumab   Rozanolixizumab   -   -   -   [2]
11,
14 
 85   Same   Ademetionine   D07128   -   -   [15]
6,
14,
22,
43,
44,
46,
47,
49,
50,
60,
84,
93,
96,
97,
172 
 86   Sodium chloride   Sodium chloride   D02056   -   -   [13]
6,
11,
13,
14,
34,
46,
51,
168,
193,
227,
228,
288,
299 
 87   Soliris   Eculizumab   D03940   [1] C5   [7] Complement and coagulation cascades, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Pertussis, Prion diseases, Staphylococcus aureus infection, Systemic lupus erythematosus   [7]
11,
13,
14,
62,
109,
222,
223 
 88   Standard of care   -   -   -   -   [8]
6,
13,
14,
49,
51,
64,
79,
85 
 89   Subcuvia   -   -   -   -   [3]
14,
49,
65 
 90   Tegeline 50mg/ml   -   -   -   -   [1]
14 
 91   Vivaglobin   Immune globulin human   -   -   -   [2]
14,
65 

Back to top